Company: DHR
Filing Date: 2025-02-20
Form Type: 10-K
Source: 0000313616-25-000043
Chunk: 27

Company: DANAHER CORP /DE/
Filing Date: 2025-02-20
Form: 10-K
Item: Item 8
Chunk 27
---
 vesting of dilutive RSUs and PSUs6.2 6.6 9.0 Weighted average MCPS converted shares— — 3.0 Weighted average common shares outstanding used in Diluted EPS737.2 743.1 737.1 Basic EPS from continuing operations$5.33 $5.70 $8.58 Diluted EPS from continuing operations$5.29 $5.65 $8.47 

69

NOTE 5.  REVENUE 

The following table presents the Company’s revenues disaggregated by geographical region and revenue type ($ in millions).  Sales taxes and other usage-based taxes collected from customers are excluded from revenue.  BiotechnologyLife SciencesDiagnosticsTotalYear ended December 31, 2024:Geographical region:North America(a)$2,237 $3,199 $4,859 $10,295 Western Europe2,296 1,574 1,587 5,457 Other developed markets(b)335 510 408 1,253 High-growth markets(c)1,891 2,046 2,933 6,870 Total$6,759 $7,329 $9,787 $23,875 Revenue type:Recurring$5,758 $4,889 $8,719 $19,366 Nonrecurring1,001 2,440 1,068 4,509 Total$6,759 $7,329 $9,787 $23,875 Year ended December 31, 2023:Geographical region:North America(a)$2,454 $2,999 $4,508 $9,961 Western Europe2,407 1,519 1,542 5,468 Other developed markets(b)329 510 431 1,270 High-growth markets(c)1,982 2,113 3,096 7,191 Total$7,172 $7,141 $9,577 $23,890 Revenue type:Recurring$5,897 $4,360 $8,425 $18,682 Nonrecurring1,275 2,781 1,152 5,208 Total$7,172 $7,141 $9,577 $23,